Manufacturing problems at a plant in Aiken, SC, last year led GlaxoSmithKline ($GSK) to recall 335,000 vials of Nicorette Lozenges. After more than a year of upgrades ...
PARSIPPANY, N.J., April 27, 2015 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare (GSKCH) today announced 2 mg and 4 mg Nicorette ® mini Lozenge is now available at most retail shelves in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback